Bio View (BIOV.TA) Stock Price

Bio View Price

TASE·CLOSED
0.63
​
Market closed

Over the last 19 years Bio View grew revenue by 1.5% annually, reaching 19.93 M ILS. Earnings per share have declined at 7.4% per year over the last 14 years. For Bio View, the net margin of -76.9% is down versus 7.2% a few years ago. At today's price the dividend yield works out to roughly 3.17%.

Bio View stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio View business model & stock analysis

Bio View Ltd, based in Rehovot, Israel, operates in the Health Care sector, specializing in the research, development, marketing, and sales of advanced imaging systems. The company manufactures and services the Duet workstation, an automated cell diagnostic system used in cytology, hematology, and pathology laboratories for detecting and analyzing abnormal cells. It also offers the ALLEGRO and ACCORD workstations for specialized applications in cancer diagnosis, minimal-residual disease monitoring, and FISH-based analyses in cytogenetics and oncology.

Frequently asked questions about Bio View

Converted at the current exchange rate, the Bio View share trades at 0.18 EUR (0.63 ILS).

The revenue cannot currently be calculated for Bio View.

The profit cannot currently be calculated for Bio View.

The P/E ratio cannot be calculated for Bio View at the moment.

The P/S cannot be calculated for Bio View currently.

The Eulerpool Quality Score for Bio View is 1/10.

The ISIN of Bio View is IL0010960495. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bio View is BIOV.TA. The ticker symbol is used to trade Bio View shares on the stock exchange.

Fair ValueTerminal
0.53 ILS
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bioview.com
Country
Israel
Currency
ILS
Initial public offering
Mar 7, 2006
ISIN
IL0010960495
Cusip
M2013W106
Market capitalization
87.61 M ILSMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
9.30
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-125.59 %
Dividend
Dividend yield
0.00 %
Payout Ratio
0.00 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
25.00 %
Last updated Oct 18, 2026, 10:23 PM

Bio View Peer Group

Bio View Ticker

TLV · BIOV.TA

Bio View FIGI

BIOV:IT · BBG000Q6J3W5

All fundamentals and in-depth analysis of Bio View

Our stock analysis for Bio View stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio View. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.